IL6 and cystic fibrosis: IL-6 has been shown to block the production of regulatory T cells (Tregs) normally induced by tumor growth factor-β (TGF-β) [82], and due to its role in maintaining the balance between Tregs and T helper 17 (Th17) cells [83], could be important for Th17-related pathology in CF.